|
61. (Journal Article): Why Clinical Trials Might Succeed in Acute Pancreatitis when They Failed in Septic Shock
Frossard JL, Morel P, Pastor CM |
»
Diabetes OD
»
Journals
»
JOP
»
2003
»
Journal Article
submitted: Oct 17, 2005 |
|
62. (Journal Article): Blue Toe Syndrome: A Rare Complication of Acute Pancreatitis
Bhalla A, Gupta S, Jain AP, Jajoo UN, Gupta OP, Kalantri SP ABSTRACT:
CONTEXT: Blue toe syndrome is an unusual complication of acute pancreatitis. It is characterized by tissue ischemia secondary to cholesterol crystal or atherothrombotic embolizatio...
|
»
Diabetes OD
»
Journals
»
JOP
»
2003
»
Journal Article
submitted: Oct 17, 2005 |
|
63. (Journal Article): Antisecretory Agents for Prevention of Post-ERCP Pancreatitis: Rationale for Use and Clinical Results
Poon RTP, Fan ST ABSTRACT:
Acute pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Over the past decade, there has been notable research on the use of var...
|
»
Diabetes OD
»
Journals
»
JOP
»
2003
»
Journal Article
submitted: Oct 17, 2005 |
|
64. (Journal Article): Antiproteasic Agents in the Prevention of Post-ERCP Pancreatitis: Rationale for Use and Clinical Results
Cavallini G, Frulloni L |
»
Diabetes OD
»
Journals
»
JOP
»
2003
»
Journal Article
submitted: Oct 17, 2005 |
|
65. (Journal Article): Antisecretory vs. Antiproteasic Drugs in the Prevention of Post-ERCP Pancreatitis: The Evidence-Based Medicine Derived from a Meta-Analysis Study
Andriulli A, Caruso N, Quitadamo M, Forlano R, Leandro G, Spirito F, De Maio G ABSTRACT:
Uncertainties still exist about the clinical benefit of pharmacological prevention of post-ERCP pancreatitis by either antisecretory drugs such as somatostatin and its long-acting ...
|
»
Diabetes OD
»
Journals
»
JOP
»
2003
»
Journal Article
submitted: Oct 17, 2005 |
|
66. (Journal Article): New Frontiers in the Pharmacological Prevention of Post-ERCP Pancreatitis: The Cytokines
Demols A, Deviere J ABSTRACT:
Acute pancreatitis is a major complication of endoscopic retrograde cholangiopancreatography (ERCP), its incidence varying with the indications for the procedure (less than 5% for ...
|
»
Diabetes OD
»
Journals
»
JOP
»
2003
»
Journal Article
submitted: Oct 17, 2005 |
|
67. (Journal Article): Acute Pancreatitis Secondary to Pancreatic Neuroendocrine Tumours
Griñó P, Martínez J, Griñó E, Carnicer F, Alonso S, Pérez-Berenguer H, Pérez-Mateo M ABSTRACT:
CONTEXT: Pancreatic neoplasms are an uncommon aetiology of acute pancreatitis. Pancreatic neuroendocrine tumours are a rare subgroup of pancreatic neoplasms. CASE REPORT: We report...
|
»
Diabetes OD
»
Journals
»
JOP
»
2003
»
Journal Article
submitted: Oct 17, 2005 |
|
68. (Journal Article): The Course of Genetically Determined Chronic Pancreatitis
Keim V, Witt H, Bauer N, Bodeker H, Rosendahl J, Teich N, Mossner J ABSTRACT:
CONTEXT: The clinical course of chronic pancreatitis in patients with mutations of cationic trypsinogen and the trypsin inhibitor SPINK1 has not yet been characterized. SETTING: Ca...
|
»
Diabetes OD
»
Journals
»
JOP
»
2003
»
Journal Article
submitted: Oct 17, 2005 |
|
69. (Journal Article): Helicobacter pylori and Pancreatic Cancer. A Working Hypothesis from Epidemiological Studies
Wöhrer S, Hejna M, Raderer M |
»
Diabetes OD
»
Journals
»
JOP
»
2003
»
Journal Article
submitted: Oct 17, 2005 |
|
70. (Journal Article): Synthetic exendin-4 (exenatide) significantly re-duces postprandial and fasting plasma glucose in subjects with type 2 diabetes.
Kolterman OG, Buse JB, Fineman MS, Gaines E, Heintz S, Bicsak TA, Taylor K, Kim D, Aisporna M, Wang Y, Baron AD ABSTRACT:
Despite the advent of new treatments, glucose control in the type 2 diabetes population is unsatisfactory. AC2993 (synthetic exendin-4; exenatide), a novel glucose-dependent insuli...
|
»
Diabetes OD
»
Disease Management
»
T2DM
»
Metabolic Control
»
Anti-Hyperglycemic a...
»
Incretin Hormones
»
Incretin Mimetics
»
Exenatide
»
Human Studies
»
Journal Article
submitted: Nov 29, 2005 |
|